Spine Wave's vertebral devices:
This article was originally published in Clinica
Executive Summary
Spine Wave has received US FDA clearance to market two complementing products for treating vertebral compression fractures - the StaXx FX structural kyphoplasty system and the CapSure PS pedicle screw. The minimally invasive StaXx FX system will allow Spine Wave to enter "a large, rapidly growing market" with what it claims is "a highly differentiated technology". The product features PEEK wafers that are stacked in situ to simultaneously distract and support the fractured vertebral body, providing pain relief and a controlled vertical fracture reduction. The CapSure product, the company adds, has a unique design that allows it to maintain maximum polyaxial angulation even when the screw is fully seated into the pedicle. The Shelton, Connecticut, firm is initiating a controlled release of both products during the second quarter of 2007, and anticipates a broader market launch by the end of this year.
You may also be interested in...
PBA Announces New Leadership; Honest Company Names CFO; Beauty Executive News
Nina Daily, chief marketing officer at the Professional Beauty Association since July 2018, will succeed Steve Sleeper as executive director at the end of June when Sleeper retires. More cosmetics industry appointments.
Biden Aims For 200 Mil. More COVID Vaccine Doses As Nervous Europe Eyes Its Borders
New round of orders would give the US all the vaccine it needs from the existing mRNA products, taking pressure off AstraZeneca as it experiences manufacturing challenges and the EU considers export restrictions to ensure it gets enough vaccine.
Listerine, Tylenol Push J&J Consumer Health To 2020 Finish Line Against Pandemic Weight
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: